#TimesUp has officially kicked the year off with a focus on women and gender inequity in Hollywood. Many of the headlines have focused on the entertainment industry, but where do women in business stand? Milena Berry, Co-Founder of PowerToFly, and Dr. Patti Fletcher, Author of "Disrupters: Success Strategies From Women Who Break The Mold," look at the progress being made on gender inequity and what still needs to be done. While business leaders identify inclusion and diversity as problems, Berry and Fletcher say that they aren't taking enough action. In some cases, Fletcher says companies are convinced that they've solved the problem already, even when that's not the case. Berry points to issues within the tech industry around company culture and hiring. She says many women aren't hired because they are not so-called "culture fits," and that's because the culture itself is the problem.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More